• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Phathom Pharmaceuticals, Inc. - Common Stock (NQ: PHAT )

    7.450 -0.050 (-0.67%)
    Streaming Delayed Price Updated: 11:50 AM EST, Dec 26, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Phathom Pharmaceuticals, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 Next >
    Attention Biotech Investors: Mark Your Calendar For These June PDUFA Dates
    May turned out to be a month of mixed fortunes as far as regulatory reviews are concerned. New molecular entity approvals, an indicator of innovation in drug research, totaled three during the month,... 
    Via Benzinga
    FDA Accepts Review Of Phathom Pharmaceuticals' NDA For Vonoprazan
    The Food and Drug Administration (FDA) has accepted for review Phathom Pharmaceuticals’ (NASDAQ: PHAT) New Drug Application (NDA) of its lead drug candidate Vonoprazan for the healing of all grades of... 
    Via Benzinga
    The Daily Biotech Pulse: Third FDA Rejection For Verrica's Skin Disease Drug, Assembly Bio Terminates Hepatitis B Virus Pact, Consistency Data For Valneva's Chikungunya Vaccine
    Here's a roundup of top developments in the biotech space over the last 24 hours. 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Tuesday
    Tuesday morning saw 454 companies set new 52-week lows. Interesting Facts About Today's 52-Week Lows: Unilever (NYSE:UL) was the largest firm by market cap to set a... 
    Via Benzinga
    The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc... 
    Via Benzinga
    81 Biggest Movers From Yesterday
    Gainers Eos Energy Enterprises, Inc. (NASDAQ: EOSE) shares gained 41.8% to settle at $1.90 on Tuesday. Eos Energy Enterprises recently reported worse-than-expected Q1 EPS and sales results. 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Phathom Pharmaceuticals: Q1 Earnings Insights
    Phathom Pharmaceuticals (NASDAQ:PHAT) reported its Q1 earnings results on Tuesday, May 10, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
    Via Benzinga
    90 Biggest Movers From Yesterday
    Gainers 
    Via Benzinga
    The Daily Biotech Pulse: Kezar Life's Lead Asset Fails, Brickell Biotech Offloads Late-Stage Asset, Connect Biopharma Ulcerative Colitis Trial Disappoints
    Here's a roundup of top developments in the biotech space over the last 24 hours. 
    Via Benzinga
    The Daily Biotech Pulse: FDA's AdComm For Acadia's Pimavanserin, Review Issues For Spero's Tebipenem Application, Cortexyme Layoffs
    Here's a roundup of top developments in the biotech space over the last 24 hours. 
    Via Benzinga
    The Week Ahead In Biotech (May 1-7): Phathom FDA Decision, Pfizer, Vertex Pharma Lead Earnings News, Ophthalmology Conference Presentations, And More
    Biotech stocks posted weekly declines yet again in the week ending April 29, taking cues from the weak broader market sentiment. Big pharma earnings, clinical readouts and pipeline updates moved stocks... 
    Via Benzinga
    Attention Biotech Investors: Mark Your Calendar For May PDUFA Dates
    The month of April was a mixed one for regulatory approvals. The Food and Drug Administration delayed approvals for at least three treatment candidates. New molecular entity, or NME, approvals, a... 
    Via Benzinga
    Phathom Pharma's Vonoprazan Commercial Preparation Update At Needham Healthcare Conference
    Via Benzinga
    Stocks That Hit 52-Week Lows On Tuesday
    During Tuesday's session, 454 stocks hit new 52-week lows. Intriguing Points From Today's 52-Week Lows: Taiwan Semiconductor (NYSE:TSM) was the largest company by... 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Gainers Bone Biologics (NASDAQ:BBLG) shar... 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Wednesday
    On Wednesday, 41 stocks made new 52-week lows. Facts of Interest About Today's 52-Week Lows: Biogen (NASDAQ:BIIB) was the biggest company by market cap to set a... 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Gainers Medigus (NASDAQ:MDGS) shares moved upwards by 12.04% to $1.62 during Thursday's pre-market session. The market value of their outstanding shares is at $38.6... 
    Via Benzinga
    Stocks That Hit 52-Week Lows On Friday
    Before 10 am on Friday, 110 companies set new 52-week lows. Interesting Points From Today's 52-Week Lows: Humana (NYSE:HUM) was the biggest company on a market cap... 
    Via Benzinga
    30 Stocks Moving in Thursday's Pre-Market Session
    Gainers InflaRx N.V. (NASDAQ: IFRX) rose 47.9% to $4.23 in pre-market trading. Raymond James upgraded InflaRx from Outperform to Strong Buy and announced a $14 price target.... 
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Gainers Nurix Therapeutics (NASDAQ:NRIX) stock moved upwards by 15.4% to $33.42 during Wednesday's regular session. Trading volume for Nurix Therapeutics's stock... 
    Via Benzinga
    46 Biggest Movers From Yesterday
    Gainers Valneva SE (NASDAQ: VALN) shares surged 39.8% to close at $39.21 on Monday after the company reported VLA2001 met both co-primary endpoints in the Phase 3 pivotal trial... 
    Via Benzinga
    64 Biggest Movers From Yesterday
    Gainers Siyata Mobile Inc. (NASDAQ: SYTA) shares jumped 83.4% to close at $5.30. Siyata Mobile released their Q2 earnings on an October 15th call that included CEO Marc... 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's After-Market Session
    Gainers Dermata Therapeutics (NASDAQ:DRMA 
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Gainers Progenity (NASDAQ:PROG) shares increased by 33.17% to $2.85 during Monday's regular session. As of 12:30 EST, Progenity's stock is trading at a volume of... 
    Via Benzinga
    34 Stocks Moving In Monday's Mid-Day Session
    Gainers Valneva SE (NASDAQ: VALN) shares jumped 34.6% to $37.75 after the company reported VLA2001 met both co-primary endpoints in the Phase 3 pivotal trial Cov-Compare.... 
    Via Benzinga
    Mid-Morning Market Update: Markets Mostly Lower; Albertsons Tops Q2 Estimates
    Following the market opening Monday, the Dow traded down 0.32% to 35,182.99 while the NASDAQ rose 0.12% to 14,915.84. The S&P also fell, dropping 0.06% to 4,468.81. The U.S.... 
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Phathom's Vonoprazan Non-Inferior To Proton Pump Inhibitor For Esophagitis Inflammation
    Phathom Pharmaceuticals Inc (NASDAQ: PHAT) has announced data from the PHALCON-EE Phase 3 trial evaluating vonoprazan versus lansoprazole for erosive esophagitis (... 
    Via Benzinga
    Phathom Pharma's Vonoprazan Inhibits Gastric Acid In Healthy Volunteers
    Phathom Pharmaceuticals Inc (NASDAQ: PHAT) has reported results from the VONO-103 Phase 1 trial of vonoprazan in healthy subjects. The trial evaluated the effects of... 
    Via Benzinga
    Director Of Phathom Pharmaceuticals Makes $587 Thousand Sale
    David A Socks, Director at Phathom Pharmaceuticals (NASDAQ:PHAT), made a large insider sell on September 22, according to a new SEC filing. What Happened: A Form 4 filing from the... 
    Via Benzinga
    Topics Regulatory Compliance
    Exposures Legal Regulatory
    < Previous 1 2 3 4 5 6 7 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.